Jeanne Magram

Company: Celsius Therapeutics

Job title: Chief Scientific Officer

Seminars:

Utilizing Single-Cell Analysis of IBD Patient Samples to Identify Disease-Driving Targets in Patient Subsets – Anti-TREM1 as an Exciting New Approach for IBD Patients 4:30 pm

Discussing matching novel therapeutic interventions to patient subsets to improve individual patient outcomes Identifying targetable disease-driving mechanisms in defined patients subsets through single-cell characterization of IBD tissue samples combined with clinical metadata Exploring the potential of TREM1 inhibition to reset the pathological relationship between the immune system and intestinal bacteria in IBDRead more

day: Day One